Resistance Patterns of Salmonella Strains in Enteric Fever: A Prospective Observational Study
DOI:
https://doi.org/10.21649/akemu.v30i4.5626Keywords:
Typhoid fever, Salmonella Typhi, XDR typhoid, fluoroquinolones, antibiotic resistance, meropenem, Ceftriaxone, Cefixime.Abstract
Background: The global threat of enteric fever is escalating due to the increasing prevalence of extended drug resistance. In Pakistan, the situation is particularly dire as the Typhi serovar exhibits rapid mutations, advancing from multi-drug resistant (MDR) to extensively drug-resistant (XDR) strains.
Objective To determine antimicrobial susceptibility of salmonella strain causing enteric fever to identify effective drugs needed to successfully treat this infection.
Methods: This cross-sectional study included 189 patients who presented with symptoms of enteric fever to Lady Reading Hospital, Peshawar, between March 15 and October 31, 2023. Out of these, 150 had culture-confirmed enteric fever. Patient details and blood culture results were meticulously recorded and analyzed using SPSS version 20.
Results: The cohort comprised 42 females (28%) and 108 males (72%). MDR strains were identified in 6 cases (4%) and XDR strains in 141 cases (94%). Notably, 36 of the XDR strains (24%) exhibited varied sensitivities to specific antibiotics. Meropenem and Imipenem were 100% effective across all samples. Azithromycin showed an efficacy rate of 94% (141 cases). Traditional first-line antibiotics like Ampicillin, Chloramphenicol, and Co-Trimoxazole showed high resistance rates of 98% (147 cases), 96% (144 cases), and 88% (132 cases), respectively. Among second-line antibiotics, Ceftriaxone, Cefixime, and Ciprofloxacin exhibited resistance rates of 94% (141 cases), 94% (141 cases), and 90% (135 cases), respectively. A significant association was found between gender and Azithromycin sensitivity (P=0.05).
Conclusion: The results of our study highlight the increasing prevalence of azithromycin resistance among Salmonella Typhi strains, while some extensively drug-resistant (XDR) strains remain susceptible to first-line medications.
References
Pitzer VE, Meiring J, Martineau FP, Watson CH, Kang G, Basnyat B, et al. The invisible burden: diagnosing and combatting typhoid fever in Asia and Africa. Clin. Infect. Dis.. 2019;69(Supplement_5);S395-S401.
Tharwani ZH, Kumar P, Salman Y, Islam Z, Ahmad S, Essar MY. Typhoid in Pakistan: Challenges, efforts, and recommendations. Infect Drug Resist 2022;15(1):2523-27.
Mumtaz MN, Irfan M, Siraj S, Khan A, Khan H, Imran M, et al. Whole-genome sequencing of extensively drug-resistant Salmonella enterica serovar Typhi clinical isolates from the Peshawar region of Pakistan. J. Infect. Public Health. 2024;17(2):271-82.
Butt MH, Saleem A, Javed SO, Ullah I, Rehman MU, Islam N, et al. Rising XDR-typhoid fever cases in Pakistan: are we heading back to the pre-antibiotic era? Front. Public Health. 2022; 9(1):1-3.
Taneja J, Khatter S, Paul M, Pandey A, Kaur I. Antimicrobial resistance in Typhoidal Salmonella in a tertiary care teaching centre in North India. Jour. Comm. Dis. 2021; 53(1): 1-4.
Wong W, Al Rawahi H, Patel S, Yau Y, Eshaghi A, Zittermann S, et al. The first Canadian pediatric case of extensively drug-resistant Salmonella Typhi originating from an outbreak in Pakistan and its implication for empiric antimicrobial choices. IDCases. 2019;15(1):1-4.
Maharjan A, Dhungel B, Bastola A, Thapa Shrestha U, Adhikari N, Banjara MR, Lekhak B, Ghimire P, Rijal KR. Antimicrobial susceptibility pattern of Salmonella spp. isolated from enteric fever patients in Nepal. Infec. Dis Rep. 2021;13(2):388-400.
Jahan N, Huq N, Yusuf MA, Morshed MS, Chhobi FK, Shamsuzzaman SM. Diagnostic Validity of Flagellin Gene (fliC) in Urine for the Detection of Typhoid Fever. Bangladesh J. Med. Microbiol. 2023;17(1):34-39.
Biswas M, Biswas S, Gupta B, Mascellino MT, Rakshit A, Chakraborty B. Changing paradigms in antibiotic resistance in Salmonella species with focus on fluoroquinolone resistance: a 5-year retrospective study of enteric fever in a tertiary Care Hospital in Kolkata, India. Antibiotics. 2022;11(10):1308-1312.
Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ, et al. Extensively drug-resistant (XDR) typhoid: evolution, prevention, and its management. BioMed Rese. Inter. 2020;2020(1):1-7.
Khan M, Tu-Zahra F, Gul A, Saleem M, Riaz M, Gul W. Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic. Inter. Jour. Infec. Dis. 2022;116(1): S4-S8.
Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio. 2018;9(1):105-118.
Shah SAA, Nadeem M, Syed SA, Abidi STF, Khan N, Bano N. Antimicrobial sensitivity pattern of Salmonella Typhi: emergence of resistant strains. Cureus. 2020;12(11):1-5.
Gupta V, Kaur H, Gupta R, Chaudhary J, Gupta M. Antibiotic Resistance among Salmonella Isolates-A Five-year Trend. Jour. Comm. Dis. 2023;55(3B):7-13.
Katiyar A, Sharma P, Dahiya S, Singh H, Kapil A, Kaur P. Genomic profiling of antimicrobial resistance genes in clinical isolates of Salmonella Typhi from patients infected with Typhoid fever in India. Sci. Rep. 2020;10(1):1-15.
Liu M, Zhu K, Li X, Han Y, Yang C, Liu H, Du X, Xu X, Yang H, Song H, Qiu S. Genetic characterization of a Salmonella enterica serovar Typhimurium isolated from an infant with concurrent resistance to ceftriaxone, ciprofloxacin and azithromycin. J Glob Antimicrob Resist. 2023;35(1):252-56.
Galeev A, Suwandi A, Bakker H, Oktiviyari A, Routier FH, Krone L, Hensel M, Grassl GA. Proteoglycan-dependent endo-lysosomal fusion affects intracellular survival of Salmonella Typhimurium in epithelial cells. Front. Immunol. 2020;11(1):1-15.
Salman HA, Abdulmohsen AM, Falih MN, Romi ZM. Detection of multidrug-resistant Salmonella enterica subsp. enterica serovar Typhi isolated from Iraqi subjects. Vet. World. 2021;14(7):1922-928.
Chatham-Stephens K, Medalla F, Hughes M, Appiah GD, Aubert RD, Caidi H, et al. Emergence of extensively drug-resistant Salmonella Typhi infections among travelers to or from Pakistan—United States, 2016–2018. Morb Mortal Wkly Rep. 2019;68(1):11-13.
Muhammad A, Khan SN, Jamal T, Haq IU, Jabbar A, Ihsan AN. Bacterial Spectrum and Antimicrobial Profile of Pediatric Blood Stream Infection at a Tertiary Care Hospital in Pakistan. Chin. Med. J. 2020;35(4):315-22.
Ahmad S, Sharif S, Ahmad N, Ali B. Antibiotic Resistance: Targeting Extensively Drug Resistant (XDR) Salmonella Typhi. National J Life Health Sci. 2024;3(2):55-64
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk